Medtronic’s (NYSE: MDT) growth efforts and investments in medical technology innovation are starting to pay off. The ...

Goldman Sachs analyst David Roman raised the firm’s price target on Medtronic (MDT) to $85 from $83 and keeps a Sell rating on the shares. The ...

Q3 2025 Earnings Call Transcript February 18, 2025 Medtronic plc beats earnings expectations. Reported EPS is $1.39, ...

Medtronic PLC (MDT) reports robust revenue and EPS growth, driven by innovations in Cardiac Ablation and Leadless Pacing, ...

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

Medtronic's stock has been static, not delivering any gains for investors. Click here to find out why MDT stock is a Buy.

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Shares of Medtronic ( MDT -6.63%) were sinking 7.3% as of 11:21 a.m. ET on Tuesday. The decline came after the medical device ...

Q3 2025 Earnings Call Feb 18, 2025, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants.

Medtronic stock skidded Tuesday after the medtech giant missed sales expectations, though profit came in well ahead of forecasts.

Monthly manufacturing data from the Empire State survey swings to a positive this morning, +5.7 versus -1.0 expected, for the fifth positive month in the past seven. This is a nice bounce-back from ...

Medtronic on Tuesday missed Wall Street estimates for third-quarter revenue due to lower purchases of its surgical devices by ...